TCL Archive Abraxane-Gemcitabine Combination Extends Overall Survival in Phase III Trial January 31, 2014
TCL Archive Bypass Budget Omits Needless Words: Faster Progress to Cost $421 Million More March 29, 1996
TCL Archive NCI Considering Adoption Of NIGMS Guidelines To Limit Growth Of Renewals, Ensure New Grants November 30, 1990